A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis

Clinical trial NCT02994927 · COMPLETED

Trial details

NCT number: NCT02994927
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

ANCA-Associated Vasculitis

Start date: 2017-03-15
Primary completion: 2019-09-07
Enrollment: 331

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.